Sleeping time after phenobarbital treatment and the brain levels of γ-aminobutyric acid and phenobarbital at the regaining of righting response point in ethionine-induced liver-disordered mice

Journal of Toxicological Sciences

Volumn 21, Issue 2, 1996, Pages 113-123

  Noguchi, Michishige ^a   Kawai, Yoshiaki ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Liver disorder; Mice; Phenobarbital; Sleeping time; aminobutyric acid

Indexed keywords

ETHIONINE; LACTIC ACID; PHENOBARBITAL; PYRUVIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; AMINO ACID BRAIN LEVEL; ANESTHESIA; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; FEMALE; LIVER DISEASE; MOUSE; NONHUMAN; SLEEP INDUCTION; SLEEP TIME;

EID: 0029994040     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.21.2_113     Document Type: Article

References (33)

1. Allan, A. M. and Harris, R. A. (1986) : Anesthetic and convulsant barubiturates alter γ-aminobutyric acid-stimulated chloride flux across brain membranes. J. Pharmacol. Exp. Ther., 238 : 763-768.
2. Berry, D. E. and Friedman, M. F. (1977) : Effect of adenine, ATP, and methionine on L-ethionine inhibition of RNA synthesis in mouse liver. Toxicol. Appl. Pharmacol., 41, 497-505.
3. Bowery, N. G. and Dray, A. (1978) : Reversal of the action of amino acid antagonists by barbiturates and other hypnotic drugs. Br. J. Phamacol., 63, 197-215.
4. Curtis, D. R. and Lodge, D. (1977) : Pentobarbitone enhancement of the inhibitory action of GABA. Nature, 270, 543-544.
5. Duncan, C. C. and Ruth, J. A. (1991) : Correlation of sedative effects with brain levels of barbiturates in LS and SS mice. Alcohol, 8, 461-466.
6. Ferenci, P., Covell, D., Schafer, D. F. et al. (1981) : Metabolism of the inhibitory neurotransmitter, γ -aminobutyric acid in a rabbit with fulminant hepatic failure. Hepatology, 3, 507-517. GABA-transaminase activity. J. Neurochem., 42, 1487-1490.
7. Ferenci, P., Covell, D., Schafer, D. F. et al. (1981) : Metabolism of the inhibitory neurotransmitter, γ -aminobutyric acid in a rabbit with fulminant hepatic failure. Hepatology, 3, 507-517. GABA-transaminase activity. J. Neurochem., 42, 1487-1490.
8. Ferenci, P., Schafer, D. F., Kleinberger, G. et al. (1982) : Serum levels of gamma-aminobutyric-acid-like activity in acute and chronic hepatocellular disease. The Lancet, October, 8, 811-812.
9. Grant, W. M. and Heel, R. C. (1991) : Vigabatrin. A review of its phamacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs., 41 : 889-926.
10. John, S. G. and Leslie, T. W. Jr. (1964) : γ-Aminobutyrate and hepatic coma. J. Lab. Clin. Med., 65, 257-267.
11. Jones. E. A., Schafer, D. F., Ferenci, P. et al. (1984) : The neurobiology of hepatic encehalopathy. Hepatology, 4, 1235-1242.
12. Kabra, P. M., Gotelli, G., Stanfill, R. et al. (1976): Simultaneous measurement of phenobarbital, diphenylhydantoin, and pridone in blood by high-pressure liquid chromatography. Clin. Chem., 22, 824-827.
13. Moroni, F., Riggio, O., Carla, V. et al. (1987): Hepatic encephalopathy : Lack of changes of γ -aminobutyric acid content in plasma and cerebrospinal fluid. Hepatology, 7, 816-820.
14. Murai, S., Nagahara, H., Saito, H. et al. (1989) : Very rapid assay of gamma-aminobutyric acid in mouse brain regions within 3 minutes by high-performance liquid chromatography with electrochemical detection. J. Pharmacol. Method., 21, 115-121.
15. Noguchi, M., Fijitsuka, T., Honda, K. et al. (1994): Effects of phenobarbital on drug metabolizing enzyme activities and other biochemical parameters in rats with DL-ethionine-induced liver injury. Toxicol. Sci., 19, 203-213.
16. Noguchi, M., Niton, S., Mabuchi, M. et al. (1996) : Effects of phenobarbital on aniline metabolism in primary liver culture of rats with ethionine-induced liver disorder. Exp. Anim., 45, in press.
17. Noguchi, M., Tanaka, K., Kuwamura, Y. et al. (1993) : Toxicokinetics of phenobarbital in rats with DL-ethionine-induced liver injury. Toxicol. Sci., 18, 245-255.
18. Oldendorf, W. H. (1971) : Brain uptake of radio-labelled amino acids, amines, and hexoses after arterial injection. Am. J. Physiol., 236: C96-C102.
19. Okazaki, H., Tokuda, H., Ishii, K. et al. (1992) : Barbiturates supress glucose utilization by inhibition of hexokinase in neuroblastoma cells. Biochem. Biophys. Res. Comm., 184: 673-679.
20. Schafer, D. F., Fowler, J. M., Munson, P. J., et al. (1983) : Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure, J. Lab. Clin. Med., 102, 870-880.
21. Schafer, D. F. and Jones, E. A. (1982) : Hepatic encephalopathy and γ-aminobutyric acid neurotransmitter system. Lancet I , 1020-1021.
22. Schouboe, A., Wu, J. Y. and Roberts, E. (1973): Purification and characterization of the 4-aminobutyrate-2-ketoglutarate transaminase from mouse brain. Biochem., 12, 2868-2873.
23. Shull, K. H. and Kisilevsky, R. (1971) : Effects of L-2-pyrrolidine-5-carboxylate on hepatic adenosine triphosphate levels in the ethionine-treated rat. Biochem. Pharmacol., 20, 2781-2785.
24. Smialowski, T. (1977) : The effect of intrahippocampal administration of γ-aminobutyric acid (GABA). In Amino Acid as Chemical Transmitters. (From, F. eds), pp. 1977-1981, Plenum Press, New York.
25. Strother, A., Throckmorton, J. K. and Herzer, C. (1971) : The influence of high sugar consumption by mice on the duration of action of barbiturates and in vitro metabolism of barbiturates, aniline and p-nitroanisole. J. Pharmacol. Exp. Ther., 179: 490-498.
26. Tanigawara, Y., Nakagawa, T. and Uno, T. (1981) : A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharm. Dyn., 4, 879-885.
27. Uchida. T. and Shikata. T. (1985) : Phathology of hepatology. Jap. J. Clin. Med., 43, 36-40. (in Japanese).
28. Laan. J. W., Weick, G., and Bleek. G. (1985) : Effects of inhibitors of GABA-transaminase or hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate. Biochem. Pharmacol., 31, 3789-3794.
29. Weizman, A., Fares, F., Pick, C, G. et al. (1989) : Chronic phenobarbital administration affects GABA and benzodiazepine receptors in the brain and periphery. Euro. J. Pharmacol., 169, 235-240.
30. Whittle, S. R. and Turner, A. J. (1982) : Differential effects of sedative and anticonvulsant barbiturates on specific [3H] GABA binding to membrane preparations from rat brain cortex. Biochem. Pharmacol., 31, 2891-2895.
31. Williams, R. L. (1983) : Drug administration in hepatic disease. N. Engl. J. Med., 309, 1616-1622.
32. Zaki, A. E. O., Ede, R. J., Davis, M. et al. (1984) : Experimental studies of blood brain barrier permeability in acute hepatic failire. Hepatology, 4, 359-363.
33. Zanchin, G., Rigotti, P., Vassanelli, P. et al. (1979) : Cerebral amino acid levels and uptake in rats after portocaval anastomosis. J. Neurosci. Res., 4, 301-310.